Vimarsana
Biggest News Aggregation in the World

Page 35 - Time Limits News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Time Limits. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Time Limits Today - Breaking & Trending Today

More Dangerous Than the Capitol Riot - Vimarsana News

More Dangerous Than the Capitol Riot

The Atlantic The most dangerous thing that happened Wednesday occurred after the mob dispersed. January 13, 2021 Anna Moneymaker / The New York Times / Redux January 6, 2021, will surely live in infamy—the day the United States Capitol was stormed by a mob, forcing legislators to evacuate in a rush and leaving five dead, including a police officer. The most dangerous part of that day for the country as a whole, however, was not what happened when the insurrectionists fought their way into the Capitol in the afternoon, but what happened just a few hours later on the floor. After all that may...

2020 Highlights In Canadian Life Sciences IP And Regulatory Law - Food, Drugs, Healthcare, Life Sciences - Vimarsana News

2020 Highlights In Canadian Life Sciences IP And Regulatory Law - Food, Drugs, Healthcare, Life Sciences

In response to the pandemic, we saw quick action and flexibility from: the Canadian Intellectual Property Office (CIPO) - deadlines from March 16 to August 28 were extended until August 31. On December 14, the Trademarks Office began accepting requests for expedited examination of trademark applications associated with medical goods or services related to COVID-19; the Federal Courts - Federal Court (FC) deadlines were suspended until June 29 or July 13, depending on the province, and a number of hearings and patent trials were conducted by Zoom.  Federal Court of Appeal (FCA) deadlines co...

Source: mondaq.com
2020 Highlights in Canadian Life Sciences IP and Regulatory Law | Smart & Biggar - Vimarsana News

2020 Highlights in Canadian Life Sciences IP and Regulatory Law | Smart & Biggar

1. COVID-19: CIPO, Federal Courts, Health Canada In response to the pandemic, we saw quick action and flexibility from: the Canadian Intellectual Property Office (CIPO) – deadlines from March 16 to August 28 were extended until August 31. On December 14, the Trademarks Office began accepting requests for expedited examination of trademark applications associated with medical goods or services related to COVID-19; the Federal Courts – Federal Court (FC) deadlines were suspended until June 29 or July 13, depending on the province, and a number of hearings and patent trials were conducted ...

COVID-19: Practical Considerations For Your Litigation, From Coast To Coast (December 4, 2020) - Litigation, Mediation & Arbitration - Vimarsana News

COVID-19: Practical Considerations For Your Litigation, From Coast To Coast (December 4, 2020) - Litigation, Mediation & Arbitration

Effective July 27, 2020, and retroactive to March 13, 2020, the Time Limits and Other Periods Act (COVID-19) suspended time limits set out in federal legislation, including the Federal Courts Act and numerous other acts pursuant to which proceedings can be instituted in the Federal Courts, until September 13, 2020 Time limits established by the Federal Courts Rules or by court order are unaffected Court of Appeal September 1: The Court's fall session has begun, and hearings will be held in person, remotely, or as hybrid hearings (with some counsel appearing in person and others remotely) Ju...

Source: mondaq.com
Strict 45-day time limit for starting PMNOC action was suspended by COVID-19 Federal legislation | Smart & Biggar - Vimarsana News

Strict 45-day time limit for starting PMNOC action was suspended by COVID-19 Federal legislation | Smart & Biggar

The Patented Medicines (Notice of Compliance) Regulations ( PMNOC Regulations) require that any section 6(1) action be brought within 45 days after the day on which the first person is served with a notice of allegation (NOA). The Federal Court has permitted such an action relating to dolutegravir (ViiV’s TIVICAY) to continue even though it was not commenced within this 45-day time limit: ViiV v Sandoz, 2020 FC 1040. Sandoz had brought a motion for summary judgment or, in the alternative, to strike the action, arguing that ViiV was statute-barred from commencing the action. The action w...